The Effect of Training Given to Nurses Caring for Dying Cancer Patients and Their Families on Care and Difficulties

September 7, 2023 updated by: Meltem Akbaş, Cukurova University

Nursing is a profession that is human and is based on nursing care. Humans are social creatures that need care from the moment they are born.Today's scientific developments and changing technology have affected the health system.Many dying patients want to be hospitalized in order to receive better care and treatment. Depending on this situation, the frequency of nurses giving care to dying patients and their families has increased in hospitals. In order to increase the quality of the care given to the dying patient and his family and to reduce the difficulties experienced while giving this care, the nurse who provides the care should have sufficient knowledge and skills about the care of the dying patient and his family.

This research will be conducted as a randomized controlled experimental study in order to determine the effect of education on the nursing care given and the difficulties experienced by the nurses who care for the dying cancer patients and their families.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The research was carried out to determine the effect of the training given to the nurses who care for the dying cancer patients and their families, on the nursing care and the difficulties experienced.

H1: There is a significant difference between the "Nursing Care Scale for Dying Patients and Their Families" pre- and post-test scores of the intervention and control groups.

H2: There is a significant difference between the pre-test and post-test scores of the "Nurse Difficulty Scale for Dying Patients and Their Families" of the intervention and control groups.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Adana, Turkey, 01330
        • Cukurova University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteer
  • Working in a clinic where adult cancer patients are hospitalized for at least 1 year

Exclusion Criteria:

  • On leave
  • Not volunteering

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Experimental Group: Nurses who met the criteria for participating in the study were informed about the study and their consent was obtained. Data collection forms were collected by the researcher at the end of the working hours. Training groups were formed on the days and times determined according to the interviews with the clinics where the research was conducted. In each hospital, training groups were formed outside the working hours of the nurses. The training was given to the nurses in the intervention group in an environment suitable for training in two days and 4 modules using interactive teaching methods. After the training, a month was waited for the nurses in the intervention group to experience care. One month after the training was given, data collection forms were distributed to the nurses in the intervention group and asked to fill in according to their self-reports.
Nursing Care and Challenges Training for Nurses Caring for Dying Cancer Patients and Their Families was given in 4 modules and 2 days.
No Intervention: Control
Control Group: Nurses who met the criteria for participating in the study were informed about the study and their consent was obtained. Data collection forms were collected by the researcher at the end of the working hours. No training was given to the control group. However, after the post-test application was made to the control group, the same training was given to the experimental group. One month later, data collection forms were distributed to the nurses in the control group and they were asked to fill in according to their self-reports. Data collection forms were collected by the researcher at the end of the working hours. Filling in the data takes about 15 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Nursing Care Scale for Dying Patients and Their Families [NCD]
Time Frame: 1 month
While the score to be obtained from each of the sub-dimensions of the scale varies between 3-15, the total score is between 15-60. The higher the score obtained from the scale, the higher the quality of nursing care.
1 month
The Nurse's Difficulty Scale for Dying Patients and Their Families [NDD]
Time Frame: 1 month
While the score to be obtained from each of the sub-dimensions of the scale varies between 3-15, the total score is between 15-60. As the score obtained from the scale increases, the difficulties experienced by the nurses increase.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Meltem Akbaş, PhD, Cukurova University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2022

Primary Completion (Actual)

January 1, 2023

Study Completion (Actual)

April 1, 2023

Study Registration Dates

First Submitted

February 22, 2023

First Submitted That Met QC Criteria

March 7, 2023

First Posted (Actual)

March 20, 2023

Study Record Updates

Last Update Posted (Actual)

September 11, 2023

Last Update Submitted That Met QC Criteria

September 7, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 05.04.2019/87

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe